Skip to main content
Novo Integrated Sciences, Inc. (NVOS)
NASDAQ: NVOS · IEX Real-Time Price · USD
0.592
+0.022 (3.93%)
May 2, 2024, 1:08 PM EDT - Market open

Novo Integrated Sciences Revenue

Novo Integrated Sciences had revenue of $13.66M in the twelve months ending February 29, 2024, with 16.91% growth year-over-year. Revenue in the quarter ending February 29, 2024 was $3.17M with 24.02% year-over-year growth. In the fiscal year ending August 31, 2023, Novo Integrated Sciences had annual revenue of $12.57M with 7.11% growth.

Revenue (ttm)
$13.66M
Revenue Growth
+16.91%
P/S Ratio
0.80
Revenue / Employee
$107,544
Employees
127
Market Cap
11.42M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Aug 31, 202312.57M834.08K7.11%
Aug 31, 202211.74M2.43M26.14%
Aug 31, 20219.31M1.44M18.38%
Aug 31, 20207.86M-1.56M-16.57%
Aug 31, 20199.42M527.36K5.93%
Aug 31, 20188.89M931.42K11.70%
Aug 31, 20177.96M784.80K10.93%
Aug 31, 20167.18M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

NVOS News

More News